Author:
Österborg A.,Ahre A.,Björkholm M.,Björeman M.,Brenning G.,Gahrton G.,Gyllenhammar H.,Johansson B.,Juliusson G.,Järnmark M.,Killander A.,Kimby E.,Lerner R.,Nilsson B.,Paul C.,Simonsson B.,Stalfelt A.-M.,Strander H.,Smedmyr B.,Svedmyr E.,Udén A.-M.,Wadman B.,Wedelin C.,Mellstedt H.
Subject
Hematology,General Medicine
Reference32 articles.
1. Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimes;Alexanian;JAMA,1969
2. Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol;Case;Am J Med,1977
3. Evaluation of intensive (VBMCP) vs standard (MP) therapy for multiple myeloma (meeting abstract);Oken;Proc Am Soc Clin Oncol,1987
4. Improved survival of increased-risk myeloma patients on combined triple-alkylating-agent therapy: at study of the CALGB;Harley;Blood,1979
5. Treatment of multiple myeloma with an intensive 5-drug combination or intermittent melphalan and prednisone: A randomized multicentre trial;Palva;Eur J Haematol,1987
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献